CrushSCI.com
Journal Selection & Manuscript Polishing Services
Pharmacological Reports journal cover Medicine
Back to journal directory

Review Cycle Records

Pharmacological Reports

Springer SCIE Non-OA
2026 Emerging Zone 32025 CAS Zone 42025 JCR Q2
113.2Average days
118Median days
36Fastest days
253Longest days
1262025 publications

Paper Review Records

All Paper Review Records

10 valid samples · Newest publication first
Review days = acceptance date − received date. PDF, DOI, and publisher-page sources are retained.

36 days

Multi-target-directed drugs: new additions in 2025 and post-marketing safety surveillance of drugs marketed in 2022–2024

AuthorsPiotr Ryszkiewicz; Marta Baranowska-Kuczko; Barbara Malinowska; Eberhard Schlicker

Affiliations1. Department of Experimental Physiology and Pathophysiology, Medical University of Białystok, Białystok, Poland; 2. Department of Experimental Physiology and Pathophysiology, Department of Clinical Pharmacy, Medical University of Białystok, Białystok, Poland; 3. Department of Pharmacology and Toxicology, University of Bonn, Bonn, Germany

Source PDF DOI Publisher page
128 days

Aripiprazole modulates splenic microbiota and immune response elicited by single prolonged stress in rats

AuthorsPeter Vargovic; Andrej Tillinger; Lubica Horvathova; Lila Dziewiczova; Jana Osacka

Affiliations1. Institute of Experimental Endocrinology, Biomedical Research Center, Slovak Academy of Sciences, Bratislava, Slovakia; 2. Faculty of Natural Sciences, Department of Animal Physiology and Ethology, Comenius University in Bratislava, Bratislava, Slovakia

Source PDF DOI Publisher page
129 days

Phase-specific involvement of BDNF–TrkB signaling in HSV-1–induced herpetic pain and its transition to postherpetic neuralgia-like pain

AuthorsIchiro Takasaki; Arata Inoue; Aoi Yoshida; Yuya Ashihara; Hiroyuki Mori

Affiliations1. Laboratory of Pharmacology, Faculty of Engineering, University of Toyama, Toyama, Japan; 2. Graduate School of Science and Engineering, University of Toyama, Toyama, Japan; 3. Graduate School of Pharma-Medical Sciences, University of Toyama, Toyama, Japan; 4. Laboratory of Pharmacology, Graduate School of Pharma-Medical Sciences, University of Toyama, Toyama, Japan

Source PDF DOI Publisher page
53 days

The Wistar-Kyoto rat as a model relevant to inattentive ADHD: substrain variability and affective comorbidity

AuthorsNatalia Gaik; Emil Dzierkacz; Agata Faron-Górecka

Affiliations1. Department of Pharmacology, Maj Institute of Pharmacology, Polish Academy of Sciences, Kraków, Poland

Source PDF DOI Publisher page
69 days

The onset of posterior reversible encephalopathy syndrome (PRES) and reversible cerebral vasoconstriction syndrome (RCVS) with the use of decongestant agents: a European pharmacovigilance analysis

AuthorsAntonietta Anatriello; Andrea Cantone; Ciro Pentella; Maria Giovanna Vastarella; Annamaria Mascolo; Annalisa Capuano; Concetta Rafaniello

Affiliations1. Campania Regional Centre for Pharmacovigilance and Pharmacoepidemiology, Napoli, Italy; 2. Department of Experimental Medicine, Section of Pharmacology “L. Donatelli”, University of Campania “Luigi Vanvitelli”, Napoli, Italy; 3. Campania Regional Centre for Pharmacovigilance and Pharmacoepidemiology, Department of Experimental Medicine, Section of Pharmacology “L. Donatelli”, University of Campania “Luigi Vanvitelli”, Naples, Italy; 4. Department of Women, Child and General and Special Surgery, University of Campania “Luigi Vanvitelli”, Naples, Italy; 5. Department of Life Sciences, Health, and Health Professions, Link Campus University, Rome, Italy

Source PDF DOI Publisher page
122 days

Topical latanoprost acid for female androgenetic alopecia: a pilot proof-of-concept trial with mechanistic evidence of prostaglandin F2α receptor activation

AuthorsAdriana Rakowska; Małgorzata Dutkiewicz; Oliwia Zegrocka-Stendel; Dorota Dymkowska; Grzegorz Huszcza; Maciej Wierzbicki; Jarosław Walczak; Lidia Rudnicka; Katarzyna Koziak

Affiliations1. Department of Dermatology, Medical University of Warsaw, Warszawa, Poland; 2. Department of Biochemistry and Nutrition, Centre for Preclinical Research and Technologies, Medical University of Warsaw, Warszawa, Poland; 3. Laboratory of Cellular Metabolism, Nencki Institute of Experimental Biology, Polish Academy of Sciences, Warszawa, Poland; 4. Department of Pharmacy, Pharmaceutical Research Institute, Warszawa, Poland; 5. BioResearch Pharma S.A., Warszawa, Poland; 6. Department of Biosystems and Soft Matter, Institute of Fundamental Technological Research, Polish Academy of Sciences, Warszawa, Poland

Source PDF DOI Publisher page
114 days

Decoding the serotonin–alcohol crosstalk: the role of central serotonergic dysregulation in alcohol use disorder

AuthorsMagdalena Zaniewska

Affiliations1. Department of Brain Biochemistry, Maj Institute of Pharmacology, Polish Academy of Sciences, Kraków, Poland; 2. Department of Affective Cognitive Neuroscience, Maj Institute of Pharmacology, Polish Academy of Sciences, Kraków, Poland

Source PDF DOI Publisher page
253 days

Investigating the interaction between aryl hydrocarbon receptor and methotrexate: implications for treatment resistance in rheumatoid arthritis patients

AuthorsAnna Wajda; Gabriela Filipowicz; Yana Kaliberda; Barbara Stypińska; Tomasz Kmiołek; Ewa Kuca-Warnawin; Małgorzata Jarończyk; Agata Matusiewicz; Bożena Jaszczyk; Małgorzata Stasiek; Anna Felis-Giemza; Katarzyna Bazała; Adam Ejma-Multański; Diana Bogucka; Ewa Modzelewska; Marzena Olesińska; Agnieszka Paradowska-Gorycka

Affiliations1. Department of Molecular Biology, National Institute of Geriatrics, Rheumatology and Rehabilitation, Warszawa, Poland; 2. Department of Pathophysiology and Immunology, National Institute of Geriatrics, Rheumatology and Rehabilitation, Warszawa, Poland; 3. National Medicines Institute, Warszawa, Poland; 4. Paediatric Regional Centre for Digital Medicine, The Children’s Memorial Health Institute, Warsaw, Poland; 5. Department of Connective Tissue Diseases, National Institute of Geriatrics, Rheumatology and Rehabilitation, Warszawa, Poland; 6. Department of Outpatient Clinics, National Institute of Geriatrics, Rheumatology and Rehabilitation, Warszawa, Poland; 7. Biologic Therapy Center, National Institute of Geriatrics, Rheumatology and Rehabilitation, Warszawa, Poland

Source PDF DOI Publisher page
84 days

Hypocholesterolemic agents and the gut microbiota: a review of interactions and modulatory activity

AuthorsManuel Mântua E. Garcia; Virginie Xavier; Ricardo C. Calhelha; Sandrina A. Heleno

Affiliations1. CIMO, LA SusTEC, Instituto Politécnico de Bragança, Campus de Santa Apolónia, Bragança, Portugal

Source PDF DOI Publisher page
144 days

Italian regional data and oropharyngeal adverse events to drugs and vaccines: insights from a 3-year spontaneous reporting (2022–2024)

AuthorsLiberata Sportiello; Mario Gaio; Alessia Zinzi; Gaetano La Mantia; Vera Panzarella; Giuseppe Colella; Paola Martina Marra; Laura Sottosanti; Simona Potenza; Giacomo Oteri; Martina Coppini; Giuseppe Seminara; Rodolfo Mauceri; Ilaria Morreale; Vittorio Fusco; Giuseppina Campisi; Annalisa Capuano

Affiliations1. Campania Regional Centre for Pharmacovigilance and Pharmacoepidemiology, University of Campania “Luigi Vanvitelli”, Naples, Italy; 2. Department of Experimental Medicine, University of Campania “Luigi Vanvitelli”, Naples, Italy; 3. Department of Life Science, Health, and Health Professions, Link Campus University, Roma, Italy; 4. Unit of Oral Medicine and Dentistry for Fragile Patients, Department of Rehabilitation, Fragility, and Continuity of Care, University Hospital Palermo, Palermo, Italy; 5. Department of Precision Medicine in Medical, Surgical and Critical Care (Me.Pre.C.C.), University of Palermo, Palermo, Italy; 6. Department of Biomedical and Dental Sciences and Morphofunctional Imaging, University of Messina, Messina, Italy; 7. Oral and Maxillofacial Surgery Unit, Multidisciplinary Department of Medical - Surgical and Dental Specialties, University of Campania “Luigi Vanvitelli”, Naples, Italy; 8. Complex Operative Unit of Stomatological surgery in Developmental age, University of Campania “Luigi Vanvitelli”, Naples, Italy; 9. Italian Medicines Agency, Rome, Italy; 10. Department of Precision Medicine in Medical, Surgical and Critical Care, University of Palermo, Palermo, Italy; 11. Internal Medicine, Pharmacovigilance and Clinical Pharmacology Unit, Department of Promoting Health, Maternal- Infant, Excellence and Internal and Specialized Medicine (PROMISE) G. D’Alessandro, Sicilian Regional Pharmacovigilance Centre, University of Palermo, Palermo, Italy; 12. Oncology Unit, Department of Medicine and Translational Medicine Unit, DAIRI - Department of Integration, Research and Innovation, “SS Antonio e Biagio e C. Arrigo” Hospital, Alessandria, Italy; 13. Department of Biomedicine, Neuroscience and Advanced Diagnostic, University of Palermo, Palermo, Italy

Source PDF DOI Publisher page

Expert Matching · Case Demo

Turn Your Submission Goalsinto a Verifiable Journal Plan

Share your field, deadline, and author profile. CrushSCI uses real review records to suggest a title direction, shortlist journals, and estimate timelines.

CrushSCI online

Client

I work in environmental engineering and need an SCI paper published within three months. I have no grant funding or prominent co-author. Which journals could I target?

CrushSCI

Yes. We will first screen for feasibility against the 90-day deadline, then identify comparable papers without grant support or prominent co-authors. The final shortlist will prioritize research quality and journal scope.

Suggested title
Machine Learning and Life-Cycle Assessment for Predicting and Optimizing Carbon Emissions in Urban Wastewater Treatment

SampleLatest 5 valid paper samples from 2026

Average review96.4 days

Median77 days

Contact CrushSCI

Contact CrushSCI

Leave your contact details so we can discuss your manuscript, editing needs, and submission plan.

Selected service: Paper Editing Service

Or leave your contact details

WhatsApp, Telegram, WeChat, and email are all optional, but at least one is required. Once received, we will contact you as soon as possible.